CA1075155A - Diuretic formulations - Google Patents
Diuretic formulationsInfo
- Publication number
- CA1075155A CA1075155A CA244,829A CA244829A CA1075155A CA 1075155 A CA1075155 A CA 1075155A CA 244829 A CA244829 A CA 244829A CA 1075155 A CA1075155 A CA 1075155A
- Authority
- CA
- Canada
- Prior art keywords
- phenoxyacetic acid
- phenoxyacetic
- ranges
- thienyl
- mole ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54659075A | 1975-02-03 | 1975-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1075155A true CA1075155A (en) | 1980-04-08 |
Family
ID=24181101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA244,829A Expired CA1075155A (en) | 1975-02-03 | 1976-01-27 | Diuretic formulations |
Country Status (8)
| Country | Link |
|---|---|
| AU (1) | AU507494B2 (enExample) |
| BE (1) | BE838170A (enExample) |
| CA (1) | CA1075155A (enExample) |
| DE (1) | DE2603890A1 (enExample) |
| FR (1) | FR2299025A1 (enExample) |
| GB (1) | GB1501592A (enExample) |
| NL (1) | NL7600500A (enExample) |
| ZA (1) | ZA76565B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2399427A1 (fr) | 1977-08-04 | 1979-03-02 | Rolland Sa A | Nouveaux sels d'addition hydrosolubles de l'acide tienilique |
| DE3275160D1 (en) * | 1982-01-04 | 1987-02-26 | Karl H Beyer | Hyperuretic agents |
| AU4777896A (en) * | 1995-02-10 | 1996-08-27 | G.D. Searle & Co. | Use of low dose amount of spironolactone for treatment of cardiovascular disease |
-
1976
- 1976-01-19 NL NL7600500A patent/NL7600500A/xx not_active Application Discontinuation
- 1976-01-27 CA CA244,829A patent/CA1075155A/en not_active Expired
- 1976-01-28 AU AU10611/76A patent/AU507494B2/en not_active Expired
- 1976-01-29 GB GB3585/76A patent/GB1501592A/en not_active Expired
- 1976-01-30 FR FR7602553A patent/FR2299025A1/fr active Granted
- 1976-02-02 ZA ZA760565A patent/ZA76565B/xx unknown
- 1976-02-02 BE BE164006A patent/BE838170A/xx unknown
- 1976-02-02 DE DE2603890*[A patent/DE2603890A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| NL7600500A (nl) | 1976-08-05 |
| BE838170A (fr) | 1976-08-02 |
| FR2299025A1 (fr) | 1976-08-27 |
| FR2299025B1 (enExample) | 1980-06-20 |
| GB1501592A (en) | 1978-02-15 |
| AU507494B2 (en) | 1980-02-14 |
| AU1061176A (en) | 1977-08-04 |
| DE2603890A1 (de) | 1976-08-05 |
| ZA76565B (en) | 1977-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3946029A (en) | Indole derivatives | |
| NO155490B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 4-)1"-hydroksy-2"-(n-imidazolyl)etyl)bibenzyl. | |
| US3958004A (en) | Phenoxyacetic acid derivatives as uricosuric agents | |
| US3644626A (en) | Novel pyridones in compositions and methods for treating inflammation pain and fever | |
| US4249021A (en) | Indanacetic acid compounds | |
| US3929872A (en) | Indanacetic acid compounds | |
| CA1075155A (en) | Diuretic formulations | |
| US4401669A (en) | 2,3-Dihydro-substituted-5-benzoyl benzofuran-2-carboxylic acids and their use in treating hypertension | |
| US4267339A (en) | Imidazo(2,1-B)thiazoles | |
| US4017632A (en) | Phenoxyacetic acid derivatives | |
| US4115402A (en) | 2,3-Dichloro-4-[(substituted-sulfonyl)-phenoxy]-acetic acids | |
| US3923994A (en) | Anti-arthritic compositions comprising a 3-aryl 2-thiohydantoin and methods of producing anti-arthritic acitvity | |
| JPS63130569A (ja) | カルボン酸アミド含有薬剤 | |
| US4042697A (en) | Isoquinolium compounds for treating diabetes | |
| US4678785A (en) | Thiadiazine compounds | |
| US3586688A (en) | Certain aminopyridinecarbonyl guanidines | |
| US3993757A (en) | Method of treating inflammation with morphanthridines | |
| JPS62106016A (ja) | 免疫抑制剤 | |
| US4585776A (en) | 4-chloro-furo-(3,4-c)-pyridine derivatives process for their preparation and therapeutical compositions containing them | |
| JPS6219577A (ja) | 新規なベンジルピペラジン誘導体および該化合物を有効成分とする医薬組成物 | |
| DD151751A5 (de) | Verfahren zur herstellung von schwefelhaltigen isochinolinderivaten | |
| JPS62294616A (ja) | 抗真菌用薬剤 | |
| US4582844A (en) | Antithrombotic 4,5 di-t-butyl-imidazole derivatives | |
| US4137320A (en) | Pharmaceutical compositions containing imidazo(2,1-b)thiazoles and process for reducing blood sugar levels therewith | |
| US4315003A (en) | Compositions containing azo compounds and use thereof for therapeutic treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |